Cilastatin
Cilastatin is a pharmaceutical compound developed by Merck Group. It is a metabolic inhibitor that works by blocking the breakdown of certain antibiotics in the body, thereby increasing their effectiveness and therapeutic potential. Cilastatin is commonly used in combination with other medications to enhance their pharmacokinetic properties and improve patient outcomes.
Lab products found in correlation
6 protocols using cilastatin
Sepsis Treatment with Cit-AuNP and Antibiotics
Solubility Enhancement and Combinatorial Antibiotic Studies
Cytotoxicity Evaluation of Chemotherapeutics
CT26 colon adenocarcinoma cells from BALB/c mice, HK-2 human proximal tubule epithelial cells, and the A549, HCC827 and H1975 human pulmonary adenocarcinoma cell lines were obtained from the American Type Culture Collection (Manassas, VA, USA). S2 and Lu85 human pulmonary small-cell carcinoma cells were kindly gifted by Dr. S. Shu (Cleveland Clinic, OH, USA). All cell lines were cultured in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS) and 10% CO2 at 37 °C. Whole human kidney lysate was obtained from Novus Biologicals (Littleton, CO, USA).
Gentamicin-Texas Red Conjugate Trafficking and Otoprotection
For in vivo imaging, GTTR or Texas Red was i.p. (100 mg/kg) or i.v. (10 mg/kg) injected into mice. Intravenous injection of 30 mg/kg cilastatin was followed by a single injection of GTTR (i.v. 10 mg/kg).
For investigations of otoprotection from cilastatin, either saline or cilastatin (360 mg/kg) was systematically administrated with i.p. injection. After 30 min, either saline or cilastatin (180 mg/kg) i.p. injection was followed by gentamicin i.p. injection (180 mg/kg). After another 30 min, both groups received a furosemide i.p. injection (100 mg/kg). These injections were repeated daily for 10 d. Note that either cilastatin (540 mg/kg) or saline i.p. injection was preceded 1 d before starting the injections as a pretreatment.
Antibiotic Delivery System Synthesis
Albumin Uptake by RPTECs Under Static and Dynamic Conditions
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!